Search

Eric Olson

Examiner (ID: 15792, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1673, 1623, 1693
Total Applications
1700
Issued Applications
960
Pending Applications
118
Abandoned Applications
631

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14893967 [patent_doc_number] => 20190290749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => IMMUNE MODULATOR AND VACCINE COMPOSITION CONTAINING THE SAME [patent_app_type] => utility [patent_app_number] => 16/345699 [patent_app_country] => US [patent_app_date] => 2017-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7892 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345699 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/345699
Immune modulator and vaccine composition containing the same Oct 29, 2017 Issued
Array ( [id] => 12707968 [patent_doc_number] => 20180127822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => MODIFIED NUCLEOTIDES METHODS AND KITS [patent_app_type] => utility [patent_app_number] => 15/792875 [patent_app_country] => US [patent_app_date] => 2017-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18935 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15792875 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/792875
Modified nucleotides methods and kits Oct 24, 2017 Issued
Array ( [id] => 17290931 [patent_doc_number] => 20210386770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 16/341777 [patent_app_country] => US [patent_app_date] => 2017-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39443 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341777 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/341777
Therapeutic agents and methods of producing same Oct 11, 2017 Issued
Array ( [id] => 12580899 [patent_doc_number] => 20180085462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION [patent_app_type] => utility [patent_app_number] => 15/729930 [patent_app_country] => US [patent_app_date] => 2017-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729930 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/729930
Topical use of levofloxacin for reducing lung inflammation Oct 10, 2017 Issued
Array ( [id] => 16175375 [patent_doc_number] => 20200222343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => METFORMIN AMINO ACID COMPOUNDS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/337994 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337994 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/337994
Metformin amino acid compounds and methods of using the same Sep 28, 2017 Issued
Array ( [id] => 12260864 [patent_doc_number] => 20180080059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'DETECTION OF OLIGOSACCHARIDES' [patent_app_type] => utility [patent_app_number] => 15/705677 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 24640 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705677 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/705677
Detection of oligosaccharides Sep 14, 2017 Issued
Array ( [id] => 13424967 [patent_doc_number] => 20180264026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 15/706604 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15706604 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/706604
IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS Sep 14, 2017 Abandoned
Array ( [id] => 14563999 [patent_doc_number] => 20190209606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => SITU GELLING COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION AND TISSUE DAMAGE [patent_app_type] => utility [patent_app_number] => 16/333434 [patent_app_country] => US [patent_app_date] => 2017-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333434 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/333434
In situ gelling compositions for the treatment or prevention of inflammation and tissue damage Sep 13, 2017 Issued
Array ( [id] => 16304132 [patent_doc_number] => 10772903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => Targeting fungi in combination with cancer therapy [patent_app_type] => utility [patent_app_number] => 15/702141 [patent_app_country] => US [patent_app_date] => 2017-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 56 [patent_no_of_words] => 16274 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15702141 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/702141
Targeting fungi in combination with cancer therapy Sep 11, 2017 Issued
Array ( [id] => 16238314 [patent_doc_number] => 20200255548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => Nanofibrillated Cellulose Fibers [patent_app_type] => utility [patent_app_number] => 16/642665 [patent_app_country] => US [patent_app_date] => 2017-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7381 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642665 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/642665
Nanofibrillated Cellulose Fibers Aug 30, 2017 Abandoned
Array ( [id] => 15816593 [patent_doc_number] => 10633462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Manufacturing process for cyclodextrin derivatives [patent_app_type] => utility [patent_app_number] => 15/693248 [patent_app_country] => US [patent_app_date] => 2017-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 29487 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693248 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/693248
Manufacturing process for cyclodextrin derivatives Aug 30, 2017 Issued
Array ( [id] => 14463013 [patent_doc_number] => 20190183145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => USE OF HUMAN MILK OLIGOSACCHARIDES IN CALVES FATTENING [patent_app_type] => utility [patent_app_number] => 16/328850 [patent_app_country] => US [patent_app_date] => 2017-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2876 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328850 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/328850
USE OF HUMAN MILK OLIGOSACCHARIDES IN CALVES FATTENING Aug 28, 2017 Abandoned
Array ( [id] => 12184021 [patent_doc_number] => 20180042958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'GALACTOSE-PRONGED POLYSACCHARIDES IN A FORMULATION FOR ANTIFIBROTIC THERAPIES' [patent_app_type] => utility [patent_app_number] => 15/688009 [patent_app_country] => US [patent_app_date] => 2017-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8977 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688009 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/688009
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies Aug 27, 2017 Issued
Array ( [id] => 18620610 [patent_doc_number] => 11753638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => Conjugated oligonucleotides [patent_app_type] => utility [patent_app_number] => 16/322212 [patent_app_country] => US [patent_app_date] => 2017-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 97 [patent_figures_cnt] => 105 [patent_no_of_words] => 27673 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322212 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322212
Conjugated oligonucleotides Aug 10, 2017 Issued
Array ( [id] => 14497781 [patent_doc_number] => 20190192545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => COMPOSITIONS AND THE USE THEREOF FOR TREATING OR PREVENTING ROSACEA [patent_app_type] => utility [patent_app_number] => 16/322434 [patent_app_country] => US [patent_app_date] => 2017-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4352 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322434 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322434
Compositions and the use thereof for treating or preventing rosacea Aug 3, 2017 Issued
Array ( [id] => 17141678 [patent_doc_number] => 20210309690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => OLIGONUCLEOTIDE SYNTHESIS [patent_app_type] => utility [patent_app_number] => 16/320918 [patent_app_country] => US [patent_app_date] => 2017-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320918 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/320918
OLIGONUCLEOTIDE SYNTHESIS Jul 24, 2017 Abandoned
Array ( [id] => 12030805 [patent_doc_number] => 20170320904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED' [patent_app_type] => utility [patent_app_number] => 15/655280 [patent_app_country] => US [patent_app_date] => 2017-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35243 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15655280 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/655280
Precipitation promoter and precipitation method in which same is used Jul 19, 2017 Issued
Array ( [id] => 14438937 [patent_doc_number] => 20190177341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => BORON-CONTAINING COMPOUND [patent_app_type] => utility [patent_app_number] => 16/320989 [patent_app_country] => US [patent_app_date] => 2017-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320989 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/320989
Boron-containing compound Jul 19, 2017 Issued
Array ( [id] => 16125937 [patent_doc_number] => 10696709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-30 [patent_title] => Phosphotriazole MRNA 5'-end cap analogs, composition comprising the same, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule, protein or peptide [patent_app_type] => utility [patent_app_number] => 16/318126 [patent_app_country] => US [patent_app_date] => 2017-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13589 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318126 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/318126
Phosphotriazole MRNA 5'-end cap analogs, composition comprising the same, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule, protein or peptide Jul 11, 2017 Issued
Array ( [id] => 12000196 [patent_doc_number] => 20170304351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES' [patent_app_type] => utility [patent_app_number] => 15/647198 [patent_app_country] => US [patent_app_date] => 2017-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12045 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15647198 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/647198
COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES Jul 10, 2017 Abandoned
Menu